Amrutanjan Health Care Ltd

NSE:AMRUTANJAN (India)  
₹ 725.20 (+1.32%) Jun 7
47.51
P/B:
7.37
Market Cap:
₹ 20.96B ($ 250.96M)
Enterprise V:
₹ 18.87B ($ 225.87M)
Volume:
34.71K
Avg Vol (2M):
86.80K
Volume:
34.71K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Amrutanjan Health Care Ltd ( NSE:AMRUTANJAN ) from 2015 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Amrutanjan Health Care stock (NSE:AMRUTANJAN) PE ratio as of Jun 09 2024 is 47.51. More Details

Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) PE Ratio (TTM) Chart

To

Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) PE Ratio (TTM) Historical Data

Total 1294
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Amrutanjan Health Care PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-09 46.8 2024-04-08 43.4
2024-06-07 46.8 2024-04-05 42.1
2024-06-06 46.2 2024-04-04 42.1
2024-06-05 45.8 2024-04-03 41.9
2024-06-04 43.0 2024-04-02 40.9
2024-06-03 44.2 2024-04-01 40.2
2024-05-31 44.6 2024-03-29 40.0
2024-05-29 45.0 2024-03-28 40.0
2024-05-28 45.0 2024-03-27 40.8
2024-05-27 44.8 2024-03-26 40.4
2024-05-24 45.6 2024-03-25 40.0
2024-05-23 47.5 2024-03-22 40.0
2024-05-22 47.0 2024-03-21 40.1
2024-05-21 47.2 2024-03-20 40.5
2024-05-20 48.1 2024-03-19 40.8
2024-05-18 47.8 2024-03-18 39.8
2024-05-17 48.1 2024-03-15 39.7
2024-05-16 48.4 2024-03-14 39.8
2024-05-15 48.2 2024-03-13 39.9
2024-05-14 48.4 2024-03-12 41.3
2024-05-13 47.4 2024-03-11 42.0
2024-05-10 48.2 2024-03-08 44.0
2024-05-09 47.3 2024-03-07 44.0
2024-05-08 49.9 2024-03-06 43.7
2024-05-07 48.5 2024-03-05 44.9
2024-05-06 48.6 2024-03-04 44.1
2024-05-03 50.0 2024-03-01 44.0
2024-05-02 50.5 2024-02-29 42.3
2024-05-01 45.1 2024-02-28 42.9
2024-04-30 45.1 2024-02-27 43.0
2024-04-29 45.8 2024-02-26 43.4
2024-04-26 44.0 2024-02-23 43.8
2024-04-25 44.5 2024-02-22 44.3
2024-04-24 43.9 2024-02-21 44.7
2024-04-23 43.4 2024-02-20 43.0
2024-04-22 43.9 2024-02-19 43.0
2024-04-19 41.2 2024-02-16 43.4
2024-04-18 41.5 2024-02-15 43.5
2024-04-17 42.0 2024-02-14 42.5
2024-04-16 42.0 2024-02-13 42.4
2024-04-15 42.5 2024-02-12 41.8
2024-04-12 41.8 2024-02-09 38.8
2024-04-11 43.3 2024-02-08 38.5
2024-04-10 43.3 2024-02-07 39.0
2024-04-09 43.1 2024-02-06 37.9

Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.